HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney.

Abstract
Renal ischemia is of clinical interest because of its role in renal failure and also renal graft rejection. To evaluate the effect of the combination of N-acetylcysteine (NAC), a potent antioxidant, sodium nitroprusside (SNP), a nitric oxide donor, and phosphoramidon (P), an endothelin converting enzyme inhibitor, on tissue protection against ischemia-reperfusion injury, we studied the biochemical and morphological changes due to 90 min of renal ischemia-reperfusion in the rat model. Ninety min of ischemia caused very severe injury and the animals could not survive after 4 days without any treatment. Whereas, animals in the treated groups survived i.e. the NAC group (25%), NAC + SNP group (43%) and in the NAC + SNP + P group (100%), 2 weeks after 90 min of ischemia. A significant increase in the serum levels of creatinine and urea nitrogen was shown in the untreated group and to a much lesser extent in the treated group, especially in the NAC + SNP + P group. The protective effect was also supported by light microscopic studies on renal tissue sections. We also measured the activities of antioxidant enzymes in tissue homogenates. With the exception of Mn-superoxide dismutase, the activities of antioxidant enzymes (catalase, glutathione peroxidase, CuZn-superoxide dismutase) were decreased in the untreated kidney. The administration of NAC alone and NAC + SNP protected against the loss of activities. Treatment with a combination of NAC, SNP and P showed a synergistic effect as evidenced by the best protection. These results suggest that pre-administration of a combination of antioxidant (NAC) with endothelin derived vasodilators (sodium nitroprusside and Phosphoramidon) attenuates renal ischemia-reperfusion injury, e.g. in donor kidney for transplantation, by protecting cells against free radical damage.
AuthorsKazushige Dobashi, Inderjit Singh, John K Orak, Kohtaro Asayama, Avtar K Singh
JournalMolecular and cellular biochemistry (Mol Cell Biochem) Vol. 240 Issue 1-2 Pg. 9-17 (Nov 2002) ISSN: 0300-8177 [Print] Netherlands
PMID12487367 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antioxidants
  • Glycopeptides
  • Nitroprusside
  • Catalase
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • phosphoramidon
  • Acetylcysteine
Topics
  • Acetylcysteine (pharmacology)
  • Animals
  • Antioxidants
  • Catalase (metabolism)
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Glutathione Peroxidase (metabolism)
  • Glycopeptides (pharmacology)
  • Ischemic Preconditioning
  • Kidney (drug effects, enzymology, pathology)
  • Male
  • Nitroprusside (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (pathology, prevention & control)
  • Superoxide Dismutase (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: